10-KAPRECIK 0001781983

Aprea Therapeutics, Inc.

Name: SEC EDGAR filing 0001558370-25-003588
Creator: Aprea Therapeutics, Inc.
License: https://www.usa.gov/government-works

Annual report (10-K) filed March 25, 2025.

Comprehensive annual report filed by U.S. public companies, including audited financial statements, MD&A, and risk factors.

Read the filing on SEC.gov All documents in this filing

New to the 10-K? What it is and how to read one

Filing facts

Accession number: 0001558370-25-003588
Filer: Aprea Therapeutics, Inc.
Ticker: APRE
CIK: 0001781983
Form type: 10-K
Form description: Annual report
Filed at: March 25, 2025
Period of report: December 31, 2024
Industry: SIC 2834Pharmaceutical Preparations
Filing size: 9.0 MB
Last verified: August 26, 2026SecFilingDex pulls from EDGAR with daily cadence

More filings from Aprea Therapeutics, Inc.

See all 41 filings from Aprea Therapeutics, Inc. →

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1781983/000155837025003588/0001558370-25-003588-index.htm ↗

Filer's full EDGAR submission history

EDGAR · Aprea Therapeutics, Inc. (0001781983) ↗

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.